Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes

Cited by (276)

Items 101–200 of 276

  1. Minimal and Maximal Models to Quantitate Glucose Metabolism: Tools to Measure, to Simulate and to Run in Silico Clinical Trials
    Claudio Cobelli, Chiara Dalla Man · 2021 · Journal of Diabetes Science and Technology
  2. Candidate Selection for Hybrid Closed Loop Systems
    Gregory P. Forlenza, Marc D. Breton, Boris P. Kovatchev · 2021 · Diabetes Technology & Therapeutics
  3. Impact of Missed and Late Meal Boluses on Glycemic Outcomes in Automated Insulin Delivery-Treated Children and Adolescents with Type 1 Diabetes: A Two-Center, Population-Based Cohort Study
    Christian Laugesen, Tobias Ritschel, Ajenthen Gayathri Ranjan, Liana J. Hsu, John Bagterp Jørgensen, Jannet Svensson, Laya Ekhlaspour, Bruce A. Buckingham, Kirsten Nørgaard · 2024 · Diabetes Technology & Therapeutics
  4. Switching to an advanced hybrid closed-loop system in real-world practice improves hypoglycemia awareness and metabolic control in adults with type 1 diabetes, particularly in those with impaired perception of hypoglycemia symptoms
    Lía Nattero‐Chávez, Edurne Lecumberri Pascual, Esther de la Calle de la Villa, Ane Bayona Cebada, Teresa Ruiz, Alejandra Quintero Tobar, Mar Lorenzo, Cristina Sánchez, Ana Izquierdo, Manuel Luque‐Ramírez et al. · 2023 · Diabetes Research and Clinical Practice
  5. Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?
    Valentina Maria Cambuli, Marco Giorgio Baroni · 2023 · International Journal of Molecular Sciences
  6. Clinical Outcomes with MiniMed TM 780G Advanced Hybrid Closed-Loop Therapy in 2- to 6-Year-Old Children with Type 1 Diabetes
    Mary Binsu Abraham, Grant J. Smith, Julie Dart, Elizabeth Ann Davis, Timothy William Jones · 2024 · Diabetes Technology & Therapeutics
  7. Unmet needs in the treatment of type 1 diabetes: why is it so difficult to achieve an improvement in metabolic control?
    Francesco Antonio Mazzotta, Lorenzo Lucaccini Paoli, Alessandro Rizzi, Linda Tartaglione, Maria Laura Leo, Valentina Popolla, Annarita Barberio, Luca Viti, Mauro A. S. Di Leo, Alfredo Pontecorvi et al. · 2024 · Nutrition and Diabetes
  8. The significance of coefficient of variation as a measure of hypoglycaemia risk and glycaemic control in real world users of the automated insulin delivery MiniMed 780G system
    Javier Castañeda, Arcelia Arrieta, Tim R. A. van den Heuvel, Ohad Cohen · 2023 · Diabetes Obesity and Metabolism
  9. Evidence from clinical trials on high-risk medical devices in children: a scoping review
    Kathrin Guerlich, Bernadeta Patro-Gołąb, Paulina Dworakowski, Alan G. Fraser, Michael Kammermeier, Tom Melvin, Berthold Viktor Koletzko · 2023 · Pediatric Research
  10. Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes
    Keren Zhou, Diana M. Isaacs · 2022 · Current Cardiology Reports
  11. Glycaemic control and variability with different commercially available hybrid closed loop systems in people with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials
    Sergio Di Molfetta, Ludovico Di Gioia, Irene Caruso, Mariangela Caporusso, Paolo Trerotoli, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola, Francesco Giorgino · 2025 · Diabetes Obesity and Metabolism
  12. MiniMed 780G Advanced Hybrid Closed-Loop System Outcomes According to Pubertal Status: Awesome Study Group Real-Life Experience
    Marianna Rachmiel, Yael Lebenthal, Kineret Mazor‐Aronovitch, Avivit Brener, Noah Levek, Talia Jacobi‐Polishook, Tal Ben Ari, Shirli Abiri, Zohar Landau, Orit Pinhas‐Hamiel · 2023 · Diabetes Technology & Therapeutics
  13. Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetes
    Nicola Shannon, Javier Castañeda, Pratik Choudhary, Ralf Kolassa, Winfried Keuthage, Jens Kroeger, Charles H. Thivolet, Mark L. Evans, Roseline Ré, Jessica Cellot et al. · 2023 · Diabetes Obesity and Metabolism
  14. Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility Criteria
    Rodolfo Javier Galindo, Grazia Aleppo, Christopher G. Parkin, David A. Baidal, Anders L. Carlson, Eda Cengiz, Gregory P. Forlenza, Davida F. Kruger, Carol Joan Levy, Janet B. McGill et al. · 2022 · Journal of Diabetes Science and Technology
  15. Automated Insulin Delivery Systems in Pediatric Type 1 Diabetes: A Narrative Review
    Peter Adolfsson, Ragnar Hanås, Dessi P. Zaharieva, Klemen Dovč, JOHAN H. JENDLE · 2024 · Journal of Diabetes Science and Technology
  16. Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System
    Jothydev Kesavadev, Anjana Basanth, Gopika Krishnan, Arun Shankar, Geethu Sanal, Sunitha Jothydev · 2023 · Diabetes Therapy
  17. Switching from treatment with sensor augmented pump to hybrid closed loop system in type 1 diabetes: impact on glycemic control and neuropsychological tests in the real world
    Amigó, Judit, Ortiz-Zúñiga, Ángel, de Urbina, Ana M. Ortiz, Sánchez, Mònica, Dos-Santos, Marcos, Abad, Mercè, Cuadra, Fátima, Simó, Rafael, Hernández, Cristina, Simó-Servat, Olga · 2023 · Diabetes Research and Clinical Practice
  18. The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System Compared to Standard Management of Type 1 Diabetes in a Singapore Setting
    Daphne Su-Lyn Gardner, Mrinmayee Lakkad, Zhiyu Qiu, Yuta Inoue, SURESH RAMA CHANDRAN, Kael Wherry · 2024 · Diabetes Technology & Therapeutics
  19. Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMedTM 670G hybrid closed-loop system in simulated trials compared to NovoLog®
    Benyamin Grosman, Di Wu, Neha Parikh, Anirban Roy, Gayane R. Voskanyan, Natalie Kurtz, Jeppe Sturis, Ohad Cohen, Magnus Ekelund, Robert Alan Vigersky · 2021 · Computer Methods and Programs in Biomedicine
  20. Safety, metabolic and psychological outcomes of Medtronic MiniMed 670G in children, adolescents and young adults: a systematic review
    Chiara Mameli, Giulia Marie Smylie, Alessio Galati, Biagio Rapone, Roque Cardona‐Hernandez, Gianvincenzo Zuccotti, Maurizio Delvecchio · 2023 · European Journal of Pediatrics
  21. Glucose control during Ramadan in a pediatric cohort with type 1 diabetes on MiniMed standard and advanced hybrid closed‑loop systems: A pilot study
    Selmen Wannes, Gehad Mohamed Gamal, Manel Ben Fredj, Dhai Al Qusayer, Sameh El Abed, Yasser Sedky, Munther Khalil · 2023 · Diabetes Research and Clinical Practice
  22. Effectiveness and Safety of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes Previously Treated with Continuous Subcutaneous Insulin Infusion and Flash Glucose Monitoring
    Noelia Gros Herguido, Sandra Amuedo, Virginia Bellido, Gema López Gallardo, Fernando Losada, Ana Pérez-Morales, Carmen Amelia Ruiz Trillo, Alfonso Soto Moreno · 2022 · Diabetes Technology & Therapeutics
  23. MiniMed 780G System Use in Type 1 Diabetes During Ramadan Intermittent Fasting: A Systematic Literature Review and Expert Recommendations
    Nancy Samir Elbarbary, Abdullah M. Alguwaihes, HAWAZEN A. ZARIF, Mohammed Hassanein, Asma Deeb, Goran Petrovski, Raed Aldahash, Reem Al Amoudi, Sufyan Hussain, Mahmoud Ashraf Ibrahim et al. · 2024 · Diabetes Technology & Therapeutics
  24. Advanced hybrid closed-loop system: first successful clinical case after total pancreatectomy
    Alessandro Rizzi, Linda Tartaglione, Mauro A. S. Di Leo, Sergio Alfieri, Dario Pitocco · 2021 · Acta Diabetologica
  25. Efficacy of advanced hybrid closed loop systems for the management of type 1 diabetes in children
    Lucia Ferrito, Stefano Passanisi, Riccardo Bonfanti, Valentino Cherubini, Nicola Minuto, Riccardo Schiaffini, Andrea Enzo Scaramuzza · 2021 · Minerva Pediatrics
  26. Diabetes Management in Transition: Market Insights and Technological Advancements in CGM and Insulin Delivery
    Tae Sang Yu, Soojeong Song, Junwoo Yea, Kyung‐In Jang · 2024 · Advanced Sensor Research
  27. Use of intermittently scanned continuous glucose monitoring in young people with high‐risk type 1 diabetes—Extension phase outcomes following a 6‐month randomized control trial
    Shelley Rose, Sara E. Styles, Esko J. Wiltshire, James Stanley, Barbara C. Galland, Martin I. de Bock, Paul A. Tomlinson, Jenny A. Rayns, Karen E. MacKenzie, Benjamin John Wheeler · 2021 · Diabetic Medicine
  28. Commercial Aspects and Market Pull of Biosensors in Diagnostic Industries
    Ashutosh Kumar, Kuldeep Mahato, Buddhadev Purohit, Pranjal Chandra · 2022 · Springer eBooks
  29. In Silico Evaluation of the Medtronic 780G System While Using the GS3 and Its Calibration-Free Successor, the G4S Sensor
    Benyamin Grosman, Neha Parikh, Anirban Roy, LOUIS J. LINTEREUR, Robert Alan Vigersky, Ohad Cohen, Andrew S. Rhinehart · 2022 · Annals of Biomedical Engineering
  30. Efficacy of automated insulin delivery in pregnant women with type 1 diabetes: a meta-analysis and trial sequential analysis of randomized controlled trials
    Tamara Teixeira, Amanda Godoi, Pedro Henrique Carvalho Leite Romeiro, João Vitor Levindo Coelho Novaes, Flavia Maria de Freitas Faria, Sacha Fernandes Pereira, Rodrigo Nunes Lamounier · 2024 · Acta Diabetologica
  31. Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system
    Yongwen Zhou, Alisa Boucsein, Venus R. Michaels, Madeleine K. Gray, Craig Jefferies, Esko J. Wiltshire, Ryan G. Paul, Amber Parry‐Strong, Maheen Pasha, Goran Petrovski et al. · 2025 · Diabetes Obesity and Metabolism
  32. Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin Delivery
    Matilda M.E. Johansson, Francesc March de Ribot, Mary-Jane Sime, Alisa Boucsein, Yongwen Zhou, Craig Jefferies, Ryan G. Paul, Esko J. Wiltshire, Mary Binsu Abraham, Timothy W. Jones et al. · 2025 · Diabetes Technology & Therapeutics
  33. Effects of hybrid closed‐loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor‐augmented pump: A prospective single‐center observational study
    Tomoaki Akiyama, Tadashi Yamakawa, Kazuki Orime, Masahiro Ichikawa, Marina Harada, Takumi Netsu, Ryoichi Akamatsu, Keita Nakamura, Satoru Shinoda, Yasuo Terauchi · 2023 · Journal of Diabetes Investigation
  34. Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the ‘CLOSE IT’ (Closed Loop Open SourcE In Type 1 diabetes) trial
    Tom Wilkinson, Dunya Tomic, Erin Boyle, David Burren, Yasser Elghattis, Alicia Josephine Jenkins, Celeste Keesing, Sonia Middleton, Natalie Nanayakkara, Jonathan A. Williman et al. · 2024 · BMJ Open
  35. Protocol for a prospective, multicenter, parallel-group, open-label randomized controlled trial comparing standard care with Closed lOoP In chiLdren and yOuth with Type 1 diabetes and high-risk glycemic control: the CO-PILOT trial
    Alisa Boucsein, Yongwen Zhou, Jillian Joy Haszard, Craig Jefferies, Esko J. Wiltshire, Sara E. Styles, Hamish R. Crocket, Barbara C. Galland, Maheen Pasha, Goran Petrovski et al. · 2024 · Journal of Diabetes & Metabolic Disorders
  36. The psychosocial outcomes of advanced hybrid closed-loop system in children and adolescents with type 1 diabetes
    Arzu Jalilova, Birsen Şentürk Pilan, Günay Demir, Burcu Özbaran, Hanife Gül Balkı, Emrullah Arslan, Sezen Köse, Samim Özen, Şükran Darcan, Damla Gökşen · 2024 · European Journal of Pediatrics
  37. Hybrid closed Loop improved glucose control compared to sensor-augmented pumps in outpatients with type 1 diabetes in real-life conditions with telehealth monitoring
    Charles H. Thivolet, Mélanie Gaudillière, Sylvie Fimbel, Nathalie Bendelac, B. Mestre, N. Protsenko, S. Brunot, Marc P Nicolino · 2021 · Acta Diabetologica
  38. Comparison of the Sensor-Augmented Pump System with the Advanced Hybrid Closed-Loop Delivery System: Quality of Life, Diabetes Distress, and Glycaemic Outcomes in a Real-Life Context
    Emmanouil S. Benioudakis, Eleni Karlafti, Argyroula E. Kalaitzaki, Maria-Alexandra Kalpou, Evangelos D. Georgiou, Christos G. Savopoulos, Triantafyllos Didangelos · 2023 · Current Diabetes Reviews
  39. User experiences during the transition to calibration-free sensors with remote monitoring while using automated insulin delivery - a qualitative study
    Shekhar Sehgal, Martin I. de Bock, Shirley Jones, Carla M. Frewen, Benjamin John Wheeler · 2023 · Frontiers in Endocrinology
  40. The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference 22‐25 February 2023 I Berlin & Online
    Afroditi Tripyla, A. Ferreira, K. Schoenenberger, Noah H. Näf, Lukas E. Inderbitzin, Luca Cossu, Giacomo Cappon, Andrea Facchinetti, D. Herzig, Lia Bally · 2023 · Diabetes Technology & Therapeutics
  41. Innovative Molecules and Delivery Technologies Enabling the Future of GLP-1-based Therapies
    Yining Xu, Daniel J. Drucker, Giovanni Traverso, Ana Beloqui · 2025 · Endocrine Reviews
  42. Can the AHCL System Be Used in T1D Patients with Borderline TDDI? A Case Report
    Anna Tekielak, Sebastian Seget, Ewa Rusak, Przemysława A. Jarosz-Chobot · 2021 · Sensors
  43. Real-World Performance of First- Versus Second-Generation Automated Insulin Delivery Systems on a Pediatric Population With Type 1 Diabetes: A One-Year Observational Study
    Bruno Bombaci, Stefano Passanisi, Mariella Valenzise, Fabio Macrì, Marco Calderone, Senad Hasaj, Sofia Zullo, Giuseppina Salzano, Fortunato Lombardo · 2023 · Journal of Diabetes Science and Technology
  44. Efficacy of the hybrid closed-loop insulin delivery system in children and adolescents with type 1 diabetes: a meta-analysis with trial sequential analysis
    Rafael Oliva Morgado Ferreira, Talita Trevisan, Eric Pasqualotto, Pedro Schmidt, Matheus Pedrotti, Janine Midori Figueiredo Watanabe, Simone van de Sande‐Lee · 2024 · Archives of Endocrinology and Metabolism
  45. Long‐term health economic evaluation of automated insulin delivery system compared with continuous subcutaneous insulin infusion pumps and CGM in a real‐world setting in Finnish paediatric and adult individuals with type 1 diabetes
    Heta‐Leena Vallivaara, Hanna A. Leppänen, Jyrki Mustonen, Antti Saari, Janne A. Martikainen, Reeta M. Rintamäki · 2025 · Diabetes Obesity and Metabolism
  46. Securing automated insulin delivery systems: A review of security threats and protective strategies
    Yuchen Niu, Siew-Kei Lam · 2025 · Computers & Security
  47. Automated Insulin Delivery in Adults With Type 1 Diabetes and Suboptimal HbA1c During Prior Use of Insulin Pump and Continuous Glucose Monitoring: A Randomized Controlled Trial
    Merete Bechmann Christensen, Ajenthen Gayathri Ranjan, Karen Rytter, Olivia M. McCarthy, Signe Schmidt, Kirsten Nørgaard · 2024 · Journal of Diabetes Science and Technology
  48. Closed-loop therapy: recent advancements and potential predictors of glycemic outcomes
    Chloë Royston, Roman Hovorka, Charlotte K. Boughton · 2025 · Expert Opinion on Drug Delivery
  49. The Medtronic 780G advanced hybrid closed-loop system achieves and maintains good glycaemic control in type 1 diabetes adults despite previous treatment
    Carmen Quirós, Núria Alonso-Carril, Silvia Rodriguez-Rodríguez, María José Barahona, Aida Orois, Andreu Simó-Servat, Montserrat Ramos, Verónica Perea · 2022 · Endocrinología Diabetes y Nutrición
  50. The Medtronic 780G advanced hybrid closed-loop system achieves and maintains good glycaemic control in type 1 diabetes adults despite previous treatment
    Carmen Quirós, Núria Alonso-Carril, Silvia Rodriguez-Rodríguez, María José Barahona, Aida Orois, Andreu Simó-Servat, Montserrat Ramos, Verónica Perea · 2023 · Endocrinología Diabetes y Nutrición (English ed )
  51. Daytime hypoglycemic episodes during the use of an advanced hybrid closed loop system
    Antonio Rossi, Laura Bacchelli Montefusco, Elia Reseghetti, Ida Pastore, Giada Rossi, Vera Usuelli, Cristian Loretelli, Denisa Boci, Moufida Ben Nasr, Francesca D’Addio et al. · 2023 · Diabetes Research and Clinical Practice
  52. Consensus statement on novel glucose-related metrics obtained through advanced medical devices: English version
    Rimei Nishimura, Yosuke Okada, Akio Kuroda, Junichi Suzuki, Yushi Hirota, Munehide Matsuhisa, Mizuki Ishiguro, Takayuki Ohno, Yuka Suganuma, Kenichi Tanaka et al. · 2025 · Diabetology International
  53. Insurance Coverage for Emerging Diabetes Technologies: Payers' Perspective
    Tim Nolan, Marie A. Frazzitta · 2021 · Diabetes Technology & Therapeutics
  54. Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children’s Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery Systems
    Thomas Simon James Crabtree, Pratik Choudhary, Alistair N. Lumb, Peter J. Hammond, Alasdair McLay, Fiona Campbell, Sze May Ng, Emma G. Wilmot, Sufyan Hussain · 2022 · Diabetes Therapy
  55. Associations between clinical and psychosocial factors and HbA1c in adult insulin pump users with type 1 diabetes
    S. Schmidt, K. P. Madsen, U. Pedersen-Bjergaard, Karen Rytter, E. Hommel, B. Cleal, I. Willaing, H. U. Andersen, K. Nørgaard · 2023 · Acta Diabetologica
  56. Efficacy and safety of closed-loop control system for type one diabetes in adolescents a meta analysis
    Mosleh Ali Jabari · 2023 · Scientific Reports
  57. Actualisation de la prise de position des experts français sur l’insulinothérapie automatisée en boucle fermée
    Éric Renard, Nadia Tubiana‐Rufi, Lucy Chaillous, Élisabeth Bonnemaison, Hélène P. Hanaire, Élise Bismuth, Michaël Joubert, R. Coutant, Pauline Schaepelynck, Jacques Beltrand et al. · 2024 · Médecine des Maladies Métaboliques
  58. Real-Life Achievements of MiniMed 780G Advanced Closed-Loop System in Youth with Type 1 Diabetes: AWeSoMe Study Group Multicenter Prospective Trial
    Noah Gruber, Avigail Wittenberg, Avivit Brener, Shirli Abiri, Kineret Mazor‐Aronovitch, Michal Yackobovitch‐Gavan, Shay Averbuch, Tal Ben Ari, Noah Levek, Neriya Levran et al. · 2024 · Diabetes Technology & Therapeutics
  59. Microvascular disease and early diabetes onset are associated with deficits in femoral neck bone density and structure among older adults with longstanding type 1 diabetes
    Fjóla Jóhannesdóttir, Trinity Tedtsen, Laura M. Cooke, Sarah Mahar, Meng Zhang, Jordan Nustad, Margaret Garrahan, Sarah Gehman, Elaine Wei-Yin Yu, Mary Bouxsein · 2024 · Journal of Bone and Mineral Research
  60. Automated Insulin Delivery Systems: Today, Tomorrow and User Requirements
    Marga Giménez, Ignacio Conget, Nick S. Oliver · 2021 · Journal of Diabetes Science and Technology
  61. A Head-to-Head Comparison of Two Algorithms for Adjusting Mealtime Insulin Doses Based on CGM Trend Arrows in Adult Patients with Type 1 Diabetes: Results from an Exploratory Study
    Martina Parise, Sergio Di Molfetta, Roberta Teresa Graziano, Raffaella Fiorentino, Antonio Cutruzzolà, Agostino Gnasso, Concetta Irace · 2023 · International Journal of Environmental Research and Public Health
  62. Combining Glucose Monitoring and Insulin Infusion in an Integrated Device: A Narrative Review of Challenges and Proposed Solutions
    Michael Schoemaker, Anna Martensson, Julia Katharina Mader, Kirsten Nørgaard, Guido Freckmann, Pierre‐Yves Benhamou, Peter Diem, Lutz Heinemann · 2023 · Journal of Diabetes Science and Technology
  63. Real-world efficacy of MiniMed™780G recommended settings (glycemic target 100 mg/dL, active insulin time 2 hours) in youth and young adults with type 1 diabetes
    Marta Bassi, Giordano Spacco, Federico Pezzotta, Margherita Di Jorgi, Giulia Siri, Andrea Pintabona, Maria Grazia Calevo, Nicola Minuto, Mohamad Maghnie · 2025 · Frontiers in Endocrinology
  64. Real‐world glycaemic outcomes observed with the use of Medtronic 780G , Tandem Control‐ IQ and Omnipod 5 automated insulin delivery systems
    Muhammad S. Khan, Sathana Sivanantham, Lavanta Farouk, Deeksha Reddy Lakshmareddy, Sara De Scolasticis, Elisabeth Cresta, Ian F. Godsland, Parizad Avari, Nick S. Oliver, Lalantha Leelarathna et al. · 2026 · Diabetic Medicine
  65. Glycemic Outcomes During Outpatient Use of Automated Insulin Delivery Without Meal Announcement in Adults with Type 1 Diabetes: Results from the CLOSE IT Randomized Controlled Trial
    Tom Wilkinson, Natalie Nanayakkara, David Burren, Alicia Jenkins, Jonathan A. Williman, Celeste Keesing, Erin Boyle, Yasser Elghattis, Alison Bennett, Tim C. Gunn et al. · 2026 · Diabetes Technology & Therapeutics
  66. A cross-sectional questionnaire study: Impaired awareness of hypoglycaemia remains prevalent in adults with type 1 diabetes and is associated with the risk of severe hypoglycaemia
    Faye Baxter, Nicola Baillie, Anna R. Dover, Roland H. Stimson, Fraser W. Gibb, Shareen Forbes · 2024 · PLoS ONE
  67. Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability
    Louis Monnier, C Colette, Éric Renard, Pierre‐Yves Benhamou, Safa Aouinti, Nicolas Molinari, David Owens · 2024 · Diabetes & Metabolism
  68. Time in tight glucose range in adolescents and young adults with diabetes during Ramadan intermittent fasting: Data from real-world users on different treatment strategies
    Nancy Samir Elbarbary, Eman Abdel Rahman Ismail · 2025 · Diabetes Research and Clinical Practice
  69. 1921–2021: From insulin discovery to islet transplantation in type 1 diabetes
    Mikaël Chetboun, Arnaud Jannin, Julie A. Kerr-Conte, François N. Pattou, Marie‐Christine Vantyghem · 2021 · Annales d Endocrinologie
  70. The Evolution of Insulin Administration in Type 1 Diabetes
    Catherina T. Pinnaro, Michael Tansey · 2021 · Journal of Diabetes Mellitus
  71. Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale
    Simona de Portu, Linda Vorrink, Roseline Ré, John Shin, Javier Castañeda, Aklilu Habteab, Ohad Cohen · 2022 · BMJ Open
  72. Effect of an Automated Advice Algorithm (CloudConnect) on Adolescent-Parent Diabetes-Specific Communication and Glycemic Management: A Randomized Trial
    Mark Daniel DeBoer, Rupa S. Valdez, John P. Corbett, Katie Krauthause, CHRISTIAN A. WAKEMAN, Alexander S. Luke, Mary Clancy Oliveri, Daniel R. Cherñavvsky, Stephen D. Patek · 2023 · Diabetes Therapy
  73. Diabetes technology including automated insulin delivery systems to manage hyperglycemia in a failing pancreatic graft: Case series of people with type 1 diabetes and a pancreas kidney or pancreas‐only transplant
    Dimitra Stathi, Thomas Johnston, Rebecca Hyslop, Anna Brackenridge, Janaka J. Karalliedde · 2023 · Journal of Diabetes Investigation
  74. An mHealth Text Messaging Program Providing Symptom Detection Training and Psychoeducation to Improve Hypoglycemia Self-Management: Intervention Development Study
    Yu Kuei Lin, James E. Aikens, Nicole de Zoysa, Diana Hall, Martha M. Funnell, Robin B Nwankwo, K Kloss, Melissa J. DeJonckheere, Rodica Pop‐Busui, Gretchen Piatt et al. · 2023 · JMIR Formative Research
  75. Automated insulin delivery systems in elderly patients with brittle type 2 diabetes
    Özge Telci Çaklılı, Ferhat Cetin, M. Kuday Özkan, Elif Şahiner, Ramazan Çakmak, Ela Keskin, Hülya Hacışahinoğulları, Enver Sukru Goncuoglu, Mehmet Temel Yilmaz · 2024 · Diabetes Research and Clinical Practice
  76. A Comparison of Glucose and Additional Signals for Three Different Exercise Types in Adolescents with Type 1 Diabetes Using a Hybrid Closed-Loop System
    Rowen Seckold, Carmel E. Smart, David Norman O'Neal, Michael Charles Riddell, Jordan Rafferty, Dale Morrison, Varuni R. Obeyesekere, JL Gooley, Barbora Paldus, Sarah Ruth Valkenborghs et al. · 2025 · Diabetes Technology & Therapeutics
  77. Efficacy and safety of a tubeless open‐source hybrid automated insulin delivery use at home among adults with type 1 diabetes mellitus: Results from a 26‐week, free‐living, randomized crossover trial
    Mengyun Lei, Ping Ling, Beisi Lin, Jing Lv, Zhigu Liu, Yongwen Zhou, Hongrong Deng, Daizhi Yang, Chaofan Wang, Xubin Yang et al. · 2025 · Diabetes Obesity and Metabolism
  78. The Tandem Control-IQ advanced hybrid system improves glycemic control in children under 18 years of age with type 1 diabetes and night rest in caregivers
    Andrés Mingorance Delgado, Fernando Lucas · 2023 · Endocrinología Diabetes y Nutrición (English ed )
  79. Women’s and Partners’ Experiences With a Closed-loop Insulin Delivery System to Manage Type 1 Diabetes in the Postpartum Period
    Maira Quintanilha, Jennifer M. Yamamoto, Breanne Aylward, Denice S. Feig, Patricia Lemieux, Helen R. Murphy, Ronald Jeremy Sigal, Josephine Ho, Heidi Virtanen, Susan G. Crawford et al. · 2024 · Canadian Journal of Diabetes
  80. Hybrid closed loop insulin therapy versus standard therapy in pregnant women with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials
    Sohaira Tahir, Shafia Naeem, Izzah Nayyab, Aafia Batool, Sameer Emeish, Ilma Hasan, Arjun Dhir, Jawad Shahid, Muhammad Abdullah Sheraz, Jaskaran Singh et al. · 2025 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  81. Significant Improvement in Glycemic Control after Initiation of AHCL in Children with Type 1 Diabetes: A Single Center Prospective Study
    Gül Yeşiltepe Mutlu, Elif Eviz, Ecem Can, Tuğba Gökçe, Serra Muradoğlu, Şükrü Hatun · 2023 · Clinical Diabetology
  82. Diabetestechnologie (Update 2023)
    Ingrid Schütz-Fuhrmann, Birgit M. Rami-Merhar, Elke Elisabeth Fröhlich-Reiterer, Sabine E. Hofer, Martin Tauschmann, Julia Katharina Mader, Michael Resl, Alexandra Kautzky‐Willer, Yvonne Winhofer-Stöckl, Markus Laimer et al. · 2023 · Wiener klinische Wochenschrift
  83. Results From a Virtual Clinic for the Follow-up of Patients Using the Advanced Hybrid Closed-Loop System
    Ana María Gómez Medina, Diana Cristina Henao, Julio David Silva León, Javier Alberto Gómez González, Óscar Múñoz, Lucia Conde Brahim, Guillermo Andrés Mecón Prada, Martín Rondón · 2023 · Journal of Diabetes Science and Technology
  84. Advanced technology for type 1 diabetes care in a deaf-mute patient
    Basilio Pintaudi, Alessandro Nani, Ilaria Gironi, Federico Bertuzzi · 2022 · BMJ Case Reports
  85. The Influence of Digital Affinity on the Continuous Glucose Monitoring System Choice by People With Type 1 Diabetes
    Carolin Kinzel, Burkhard J. Manfras · 2022 · Journal of Diabetes Science and Technology
  86. Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data
    Lisa A. de Jong, Xinyu Li, Sajad Emamipour, Sjoukje van der Werf, Maarten Jacobus Postma, Peter Ruben van Dijk, Talitha Feenstra · 2024 · PharmacoEconomics
  87. Empfehlungen zur Diabetes-Behandlung mit automatischen Insulin-Dosierungssystemen
    Thekla von dem Berge, Sarah Biester, Torben Biester, Anne-Kathrin Buchmann, Nicolin Datz, Ute Grosser, Kerstin Kapitzke, Britta Klusmeier, K Remus, Felix Reschke et al. · 2021 · Diabetologie und Stoffwechsel
  88. Delivering evidence-based interventions for type 1 diabetes in the virtual world – A review of UK practice during the SARS-CoV-2 pandemic
    Abhishek Sathyanarayanan, Thomas Simon James Crabtree, Pratik Choudhary, Daisy Elliott, Mark L. Evans, Alistair N. Lumb, Emma G. Wilmot · 2022 · Diabetes Research and Clinical Practice
  89. Improving glycemic control by transitioning from the MiniMedTM 640G to 770G in Japanese adults with type 1 diabetes mellitus: a prospective, single-center, observational study
    Satoshi Kubota, Ai Sato, Manami Hosokawa, Yosuke Okubo, Shohei Takayama, Atsuko Kaneko, Yasuho Shimada, Yuki Asano, Yoshihiko Sato, Masanori Yamazaki et al. · 2024 · Endocrine Journal
  90. Cost-Effectiveness of Intermittently Scanned Continuous Glucose Monitoring Versus Advanced Hybrid Closed-Loop Systems in Type 1 Diabetes: Comment on Jendle et al.
    Fleur Levrat‐Guillen, Tara Ghazi · 2022 · Diabetes Therapy
  91. Real‐world glycaemic outcomes in children and young people on advanced hybrid closed‐loop therapy: A population‐based study in Western Australia
    Frances Ellen Gehrmann, Grant J. Smith, Kathleen Irwine, Katrina L. Ellis, Elizabeth Ann Davis, Timothy William Jones, Craig E. Taplin, Mary Binsu Abraham · 2024 · Journal of Paediatrics and Child Health
  92. Effect of Automated Insulin Delivery System Therapy at Diagnosis on Metabolic Control in Children and Adolescents with Type 1 Diabetes
    Uğur Cem Yılmaz, Günay Demir, Deniz Özalp Kızılay, Samim Özen, Damla Gökşen · 2025 · Diabetes Therapy
  93. Experiences with Simplera sync™ all‐in‐one sensors and extended wear infusion sets in adolescents and young adults using the MiniMed ™ 780G : A qualitative study
    Venus R. Michaels, Hamish R. Crocket, Alisa Boucsein, Yongwen Zhou, Ryan G. Paul, Esko J. Wiltshire, Craig Jefferies, Martin I. de Bock, Benjamin John Wheeler · 2025 · Diabetic Medicine
  94. Extended Use of Automated Insulin Delivery in Young People with Type 1 Diabetes and Elevated HbA1c: 52-Week Outcomes of the CO-PILOT Trial
    Marcus C Ward, Alisa Boucsein, Yongwen Zhou, Venus R. Michaels, Jillian Joy Haszard, Craig Jefferies, Esko J. Wiltshire, Ryan G. Paul, Caleb A Lopez-Sanchez, Martin I. de Bock et al. · 2026 · Diabetes Technology & Therapeutics
  95. Learning control-ready forecasters for Blood Glucose Management
    Harry Rubin‐Falcone, Joyce M. Lee, Jenna Wiens · 2024 · Computers in Biology and Medicine
  96. Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled clinical trial in patients with type 1 diabetes
    Lía Nattero‐Chávez, Esther de la Calle de la Villa, Edurne Lecumberri Pascual, Ane Bayona Cebada, Teresa Ruiz Gracia, Alejandra Quintero Tobar, Mar Lorenzo Moñino, Cristina Sánchez Rodríguez, Ana Izquierdo, Héctor Francisco Escobar-Morreale et al. · 2024 · Therapeutic Advances in Endocrinology and Metabolism
  97. Electrocardiograpic responses during spontaneous hypoglycaemia in people with type 1 diabetes and impaired awareness of hypoglycaemia
    Peter Novodvorský, Alan Bernjak, Ellen Downs, Amelia Smith, Muhammad Fahad Arshad, Andrei I. Oprescu, Richard Jacques, Justin Lee, Simon R. Heller, Ahmed Iqbal · 2025 · Diabetic Medicine
  98. The Effect of Do-It-Yourself Real-Time Continuous Glucose Monitoring on Glycemic Variables and Participant-Reported Outcomes in Adults With Type 1 Diabetes: A Randomized Crossover Trial
    Shekhar Sehgal, Mona M. Elbalshy, Jonathan A. Williman, Barbara C. Galland, Hamish R. Crocket, Rosemary M. Hall, Ryan G. Paul, Robert Leikis, Martin I. de Bock, Benjamin John Wheeler · 2023 · Journal of Diabetes Science and Technology
  99. Clinical Translation and Implementation of a Bioartificial Pancreas Therapy: A Qualitative Study Exploring the Perspectives of People With Type 1 Diabetes
    Dide de Jongh, Silke Lapré, Behiye Özcan, Robert Zietse, Eline Maria Bunnik, Emma K. Massey · 2024 · Transplantation Direct
  100. First in Human Feasibility Study: Automated Insulin Delivery Utilizing a Self-Adapting Algorithm in Adults With Type 1 and Type 2 Diabetes
    Tom Wilkinson, Solita Donnelly, Claire S. Lever, Jonathan A. Williman, Renee A. Meier, Alisa Boucsein, Shirley Jones, Dave Ballagh, Reon van Rensburg, Rachael Sampson et al. · 2025 · Journal of Diabetes Science and Technology